WHO ICTRP trial

Marine oxygen carrier (M101) for organ preservation in liver transplantation; a…

ACTRN12623000301662 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12623000301662
Public title Marine oxygen carrier (M101) for organ preservation in liver transplantation; a randomised exploratory study.
Scientific title The effect of marine oxygen carrier (M101) during cold static storage on the incidence of ischaemia reperfusion injury in liver transplantation; a randomised exploratory study.
Primary sponsor A/Prof Louise Barbier
Secondary sponsors Prof John McCall
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries New Zealand
Conditions Liver Transplantation; Liver Transplantation;Surgery - Other surgery;Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Interventions We will assess outcome after liver transplantation using grafts from deceased donors after brain death that have been perfused with University of Wisconsin solution (UWS) plus the oxygen carrier molecule M101 (HemO2life, Morlaix, France)…
Registration date Mar 17, 2023
Target size 20
Secondary IDs Nil known
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations